COVID-19 treatment | Cipla eyes multi-drug portfolio for novel coronavirus cure: Report

Cipla is reportedly fine tuning its pact with United States-based Gilead Sciences Inc. on patented intravenous drug remdesivir, a potential treatment for the respiratory infection.

from Moneycontrol Business News https://www.moneycontrol.com/news/business/covid-19-treatment-|-cipla-eyes-multi-drug-portfolio-for-novel-coronavirus-cure-report_13791741.html